| # | Drug | Count |
|---|---|---|
| 0 | SITAGLIPTIN | 39 |
| 1 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 19 |
| 2 | ASPIRIN | 15 |
| 3 | ASPIRIN 325 MG | 15 |
| 4 | ASPIRIN 81 MG | 15 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 15 |
| 6 | OMEPRAZOLE MAGNESIUM | 12 |
| 7 | ADALIMUMAB | 11 |
| 8 | METFORMIN | 11 |
| 9 | OMEPRAZOLE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LURBINECTEDIN | 4 | 0.0034 |
| 1 | DACOMITINIB | 1 | 0.0013 |
| 2 | SODIUM HYALURONATE | 1 | 0.0012 |
| 3 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 19 | 0.0009 |
| 4 | SUGAMMADEX SODIUM | 1 | 0.0008 |
| 5 | NATEGLINIDE | 1 | 0.0007 |
| 6 | DALTEPARIN SODIUM | 6 | 0.0006 |
| 7 | SITAGLIPTIN | 39 | 0.0005 |
| 8 | EDOXABAN TOSYLATE | 3 | 0.0004 |
| 9 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Proton Pump Inhibitor [EPC] | 25 |
| 2 | Corticosteroid [EPC] | 19 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 4 | Platinum-based Drug [EPC] | 15 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 |
| 6 | Insulin Analog [EPC] | 11 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 8 | Loop Diuretic [EPC] | 9 |
| 9 | GLP-1 Receptor Agonist [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 2 | Glinide [EPC] | 2 | 0.0002 |
| 3 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Phenothiazine [EPC] | 3 | 0.0001 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |